Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
US Department of Justice
Farmers Insurance

Generated: December 15, 2017

DrugPatentWatch Database Preview

VASOCON Drug Profile

« Back to Dashboard

Which patents cover Vasocon, and when can generic versions of Vasocon launch?

Vasocon is a drug marketed by Novartis and is included in two NDAs.

The generic ingredient in VASOCON is antazoline phosphate; naphazoline hydrochloride. Additional details are available on the antazoline phosphate; naphazoline hydrochloride profile page.

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
NovartisVASOCONnaphazoline hydrochlorideSOLUTION/DROPS;OPHTHALMIC080235-002Mar 24, 1983DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
NovartisVASOCON-Aantazoline phosphate; naphazoline hydrochlorideSOLUTION/DROPS;OPHTHALMIC018746-002Jul 11, 1994DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Army
Federal Trade Commission
Cantor Fitzgerald
Harvard Business School
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: